Co-beneldopa (Benserazide/levodopa) Prescribing at THE HOUSE PARTNERSHIP
Drugs used in parkinsonism and related disorders | Central Nervous System
Items (12m)
329
Total Quantity
47.0K
NHS Cost
£3.2K
vs National Avg
+117.6%
THE HOUSE PARTNERSHIP prescribed 329 items of Co-beneldopa (Benserazide/levodopa) over the last 12 months at a cost of £3,164 to the NHS. This is 117.6% above the national average prescribing rate. Co-beneldopa (Benserazide/levodopa) is classified under Drugs used in parkinsonism and related disorders in the BNF.
Monthly Prescribing Trend
Jul 2026
23
Jul 2026
25
Jul 2026
21
Jul 2026
26
Jul 2026
24
Jul 2026
33
Jul 2026
33
Jul 2026
47
Jul 2026
17
Jul 2026
23
Jul 2026
27
Jul 2026
30
Prescribing Details
| Total Items | 329 |
|---|---|
| Total Quantity | 47,000 |
| Total NHS Cost | £3,164 |
| Presentations | 9 different forms |
| vs National Average | +117.6% |
Co-beneldopa (Benserazide/levodopa) Prescribing Comparison
| This practice | 329 items |
|---|---|
| National average per practice | 151 items |
| Difference | +117.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.